Bayer

This study observes children aged 7 to 12 with hemophilia A who are already prescribed damoctocog alfa pegol, a medicine that replaces missing clotting factor. Researchers will collect data from routine care over two years to see how well the drug prevents bleeding episodes. No e…

This study looks at the safety of a drug called finerenone for children and young adults (birth to 18 years) with heart failure and left ventricular systolic dysfunction (LVSD). Participants take finerenone along with their usual heart medications for up to 9 months. The study tr…

This study looks at how well darolutamide (a newer drug) plus standard hormone therapy works in Chinese men whose prostate cancer has become resistant to earlier treatment but hasn't spread. About 800 men will take part, and researchers will check if their PSA levels drop very lo…

This early-stage study looks at whether it is safe to take nitroglycerin spray together with a new drug called nurandociguat in people with stable coronary artery disease. Both drugs widen blood vessels, so combining them might cause a sudden drop in blood pressure. The study wil…

This study looks at whether a digital tool called Luscii is practical and acceptable for people with transthyretin amyloid cardiomyopathy (ATTR-CM), a rare heart condition. About 60 adults in Austria, Germany, and Italy will use the app at home to share health information with th…

This study will follow 500 adults in Spain with chronic kidney disease and type 2 diabetes who are taking finerenone. Researchers want to see if a tool called the Klinrisk score, which estimates kidney disease progression, improves after 2 years of treatment. The study will colle…